GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LBX Pharmacy Chain JSC (SHSE:603883) » Definitions » Piotroski F-Score

LBX Pharmacy Chain JSC (SHSE:603883) Piotroski F-Score : 5 (As of May. 05, 2024)


View and export this data going back to 2015. Start your Free Trial

What is LBX Pharmacy Chain JSC Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

LBX Pharmacy Chain JSC has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for LBX Pharmacy Chain JSC's Piotroski F-Score or its related term are showing as below:

SHSE:603883' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 7
Current: 5

During the past 13 years, the highest Piotroski F-Score of LBX Pharmacy Chain JSC was 7. The lowest was 3. And the median was 5.


LBX Pharmacy Chain JSC Piotroski F-Score Historical Data

The historical data trend for LBX Pharmacy Chain JSC's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBX Pharmacy Chain JSC Piotroski F-Score Chart

LBX Pharmacy Chain JSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 6.00 5.00 7.00 5.00

LBX Pharmacy Chain JSC Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 5.00 5.00 5.00

Competitive Comparison of LBX Pharmacy Chain JSC's Piotroski F-Score

For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBX Pharmacy Chain JSC's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where LBX Pharmacy Chain JSC's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was 221.912 + 203.315 + 212.463 + 321.258 = ¥959 Mil.
Cash Flow from Operations was 187.88 + 392.159 + 1300.609 + 417.072 = ¥2,298 Mil.
Revenue was 5370.345 + 5230.667 + 6395.962 + 5539.13 = ¥22,536 Mil.
Gross Profit was 1742.316 + 1676.269 + 2089.342 + 1949.747 = ¥7,458 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(21293.749 + 20991.474 + 21325.004 + 21231 + 21371.555) / 5 = ¥21242.5564 Mil.
Total Assets at the begining of this year (Mar23) was ¥21,294 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,352 Mil.
Total Current Assets was ¥9,195 Mil.
Total Current Liabilities was ¥10,326 Mil.
Net Income was 214.706 + 153.122 + 175.339 + 291.334 = ¥835 Mil.

Revenue was 4850.416 + 4785.357 + 6399.096 + 5440.516 = ¥21,475 Mil.
Gross Profit was 1519.912 + 1576.038 + 1914.472 + 1795.335 = ¥6,806 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(18446.687 + 19818.636 + 20268.37 + 21397.333 + 21293.749) / 5 = ¥20244.955 Mil.
Total Assets at the begining of last year (Mar22) was ¥18,447 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,189 Mil.
Total Current Assets was ¥9,151 Mil.
Total Current Liabilities was ¥10,721 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

LBX Pharmacy Chain JSC's current Net Income (TTM) was 959. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

LBX Pharmacy Chain JSC's current Cash Flow from Operations (TTM) was 2,298. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=958.948/21293.749
=0.04503425

ROA (Last Year)=Net Income/Total Assets (Mar22)
=834.501/18446.687
=0.04523853

LBX Pharmacy Chain JSC's return on assets of this year was 0.04503425. LBX Pharmacy Chain JSC's return on assets of last year was 0.04523853. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

LBX Pharmacy Chain JSC's current Net Income (TTM) was 959. LBX Pharmacy Chain JSC's current Cash Flow from Operations (TTM) was 2,298. ==> 2,298 > 959 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=3352.062/21242.5564
=0.15779937

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=3189.149/20244.955
=0.15752809

LBX Pharmacy Chain JSC's gearing of this year was 0.15779937. LBX Pharmacy Chain JSC's gearing of last year was 0.15752809. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=9195.201/10325.787
=0.89050849

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=9150.791/10721.083
=0.85353233

LBX Pharmacy Chain JSC's current ratio of this year was 0.89050849. LBX Pharmacy Chain JSC's current ratio of last year was 0.85353233. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

LBX Pharmacy Chain JSC's number of shares in issue this year was 584.105. LBX Pharmacy Chain JSC's number of shares in issue last year was 582.667. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=7457.674/22536.104
=0.33092117

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=6805.757/21475.385
=0.31690966

LBX Pharmacy Chain JSC's gross margin of this year was 0.33092117. LBX Pharmacy Chain JSC's gross margin of last year was 0.31690966. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=22536.104/21293.749
=1.05834365

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=21475.385/18446.687
=1.16418656

LBX Pharmacy Chain JSC's asset turnover of this year was 1.05834365. LBX Pharmacy Chain JSC's asset turnover of last year was 1.16418656. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+1+0+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

LBX Pharmacy Chain JSC has an F-score of 5 indicating the company's financial situation is typical for a stable company.

LBX Pharmacy Chain JSC  (SHSE:603883) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


LBX Pharmacy Chain JSC Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of LBX Pharmacy Chain JSC's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


LBX Pharmacy Chain JSC (SHSE:603883) Business Description

Traded in Other Exchanges
N/A
Address
No. 288, Xiangya Road, Kaifu District, Hunan, Changsha, CHN, 410005
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.

LBX Pharmacy Chain JSC (SHSE:603883) Headlines

No Headlines